Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.54 |
| ▸ | HPGD | P15428 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.50 |
| ▸ | FEN1 | P39748 | 1/20 | 0.50 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | HEXA | P06865 | 3/20 | 0.48 |
| ▸ | HEXB | P07686 | 3/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | MPI | P34949 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24169113 | 0.88 | TDP1 (0.58) | TDP1ALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL25760753 | 0.85 | TDP1 (0.63) | TDP1ALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL5865650 | 0.85 | PIN1 (0.51) | TDP1ALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL3674674 | 0.85 | ALDH1A1 (0.49) | ALDH1A1KDM4EMEN1KMT2AMAPT | |
| SCHEMBL29439840 | 0.85 | ALDH1A1 (0.49) | ALDH1A1KDM4EMEN1KMT2AMAPT | |
| SCHEMBL2957046 | 0.84 | TDP1 (0.62) | TDP1ALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL4311303 | 0.83 | TDP1 (0.60) | TDP1ALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL8778085 | 0.83 | TNF (0.44) | TDP1ALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL2959934 | 0.82 | ALDH1A1 (0.64) | TDP1ALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL13898509 | 0.79 | ALDH1A1 (0.56) | TDP1ALDH1A1KDM4EHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1433527-B1 | CATALYSTS COMPRISED OF N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | DAICEL CHEM (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-7759515-B2 | Catalyst comprising N-substituted cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-07-20 | — | — | US | disclosed |
| US-20060229196-A1 | Catalyst comprising n-substituted cyclic imide compound and process for producing organic compounds using the catalyst | ISHII YASUTAKA | 2006-10-12 | — | — | US | disclosed |
| US-7084090-B2 | Catalyst comprised of n-substituted cyclic imides and processes for preparing organic compounds with the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-01 | — | — | US | disclosed |
| CN-1264607-C | Catalysts comprised of N-substituted cyclic imides and processes for preparing organic compounds with catalysts | DAICEL CHEM (JP) | 2006-07-19 | — | — | CN | disclosed |
| EP-1433527-A1 | CATALYSTS COMPRISED OF N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 2004-06-30 | — | — | EP | disclosed |
| US-20040053778-A1 | Catalyst comprised of n-substituted cyclic imides and processes for preparing organic compounds with the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
| CN-1476352-A | Catalysts comprised of N-substituted cyclic imides and processes for preparing organic compounds with catalysts | ����贻�ѧ��ҵ��ʽ���� | 2004-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229196-A1 | Catalyst comprising n-substituted cyclic imide compound and process for producing organic compounds using the catalyst | NOS2, NOS1, NOS3 | TDP1 3824/4885ALDH1A1 1553/4885KDM4E 3183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.